DataMeds AI Inc. logo

MEDS

DataMeds AI Inc. · NASDAQ

Website
Market cap
$3.1M

DataMeds AI Inc. (MEDS) is an Other Pharmaceuticals company listed on NASDAQ. In the last 30 days Quantisnow tracked 9 wire items for MEDS, including 8 market updates and 1 press release or news item. The most recent was published Nov 16, 2026.

DataMEDS AI, Inc. (NASDAQ:MEDS), formerly Wellgistics Health, Inc., is a healthcare company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units through its health information technology platforms to deliver a better experience for consumers and providers. Headquartered in Tampa, Fla., DataMEDS incorporates its EinsteinRx artificial intelligence platform and PharmacyChain blockchain-enabled smart contracts platform into the Health Lives Here mobile application from Tollo Health, LLC, and its pharmacy-related Corexa Health subsidiary provides pharmacy dispensing and pharmacy-related services, including distribution of products developed by Tollo Health. DataMEDS also owns Helomics Corporation, a Pittsburgh, PA -based commercial clinical molecular diagnostics laboratory focused on the ChemoFx Assay chemotherapy selection diagnostics test that aims to help oncologists make chemotherapy treatment decisions.

Financial highlights

Full financials
Revenue, TTM
$7.68M
Revenue growth
-77.5%
Net income, TTM
-$43.37M
Net margin
-564.8%
Cash
$476.6K

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

News · 26 weeks39-62%
2026-05-24: 02026-05-31: 12026-06-07: 02026-06-14: 02026-06-21: 02026-06-28: 02026-07-05: 02026-07-12: 02026-07-19: 22026-07-26: 42026-08-02: 22026-08-09: 32026-08-16: 12026-08-23: 22026-08-30: 02026-09-06: 12026-09-13: 32026-09-20: 22026-09-27: 42026-10-04: 12026-10-11: 42026-10-18: 42026-10-25: 02026-11-01: 32026-11-08: 12026-11-15: 1
2026-05-242026-11-15
Mix2690d
  • Market22(85%)
  • Other3(12%)
  • Offering1(4%)
Activity · 52 weeks3933 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

MEDS FAQ

10 questions
  • What does DataMeds AI Inc. do?
    DataMEDS AI, Inc. (NASDAQ:MEDS), formerly Wellgistics Health, Inc., is a healthcare company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units through its health information technology platforms to deliver a better experience for consumers and providers. Headquartered in Tampa, Fla., DataMEDS incorporates its EinsteinRx artificial intelligence platform and PharmacyChain blockchain-enabled smart contracts platform into the Health Lives Here mobile application from Tollo Health, LLC, and its pharmacy-related Corexa Health...
  • What is the latest news on MEDS?
    In the last 30 days Quantisnow tracked 9 wire items for MEDS: 8 market updates and 1 press release or news item. The most recent was published on November 16, 2026.
  • What is MEDS revenue?
    DataMeds AI Inc. (MEDS) reported $7.68M of revenue for the twelve months ended Sep 30, 2026. That is down 77.5% from the year before. Revenue for fiscal 2025 was $23.34M.
  • Is MEDS profitable?
    No. DataMeds AI Inc. reported a net loss of $43.37M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does MEDS have?
    DataMeds AI Inc. reported $476.6K in cash and cash equivalents and $18.16M of debt on its most recent balance sheet in SEC filings.
  • Where does MEDS stock trade?
    DataMeds AI Inc. (MEDS) is listed on NASDAQ.
  • What sector and industry is MEDS in?
    DataMeds AI Inc. operates in the Health Care sector, Other Pharmaceuticals industry.
  • What are analysts saying about MEDS?
    DataMeds AI Inc. has had 1 recent analyst action on file. The most recent action was from EF Hutton: Buy with a $4.50 price target on 2021-12-09. Recent price targets cluster around $4.50.
  • What companies are similar to MEDS?
    Notable peers in the same industry include GH (Guardant Health Inc.), GDRX (GoodRx Holdings Inc.), HIMS (Hims & Hers Health Inc.), PGNY (Progyny Inc.), VCYT (Veracyte Inc.). Compare MEDS side-by-side with any of them on Quantisnow.
  • How can I track MEDS on Quantisnow?
    Quantisnow aggregates DataMeds AI Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MEDS to receive live email and push alerts on every new disclosure.